Reduced serum levels of dehydroepiandrosterone sulphate in adrenal incidentalomas: a marker of adrenocortical tumour
Authors:
- 1 February 1995
- journal article
- Published by Wiley in Clinical Endocrinology
- Vol. 42 (2) , 129-134
Abstract
Summary: BACKGROUND AND OBJECTIVE Reduced serum levels of dehydroeplandrosterone sulphate (DHEAS) have been shown In patients with Cushing's syndrome resulting from adrenocortical adenoma, In contrast with normal DHEAS levels In patients with Cushing's disease. The elm of this study was to verify whether patients with incidentally discovered adrenocortical adenomas also have reduced levels of DHEAS.DESIGN Evaluation of serum DHEAS, serum and urinary cortisol, plasma ACTH and low dose dexamethasone suppression test In patients with adrenal Incidentaloma and Cushing's syndrome.PATIENTS Thirty‐two patients with adrenal Incidentaloma and, as controls, 17 patients with overt Cushing's syndrome, were studied.RESULTS Serum DHEAS levels lower than normal were found In 21/24 (81.5 %) patients with adrenocortical Incidentaloma, but In only 1/8 patients with a mass of non‐adrenocortical origin. This patient had massive bilateral metastatic infiltration of both adrenal glands and primary adrenal failure. The prevalence of low DHEAS levels in the two groups was significantly different (P= 00001). In patients with adrenocortical Incidentaloma, the prevalence of low DHEAS levels was significantly higher (P= 00001) than that found for some hormonal alterations Indicating pre‐clinical hypercortlsoilsm (high urinary cortisol, unsuppressed serum cortisol after low dose dexamethasone administration and low plasma ACTH). Low DHEAS levels were found in all patients with Cushing's syndrome due to adrenocortical adenoma but in none of those with Cushing's disease. CONCLUSIONS Our results Indicate that the finding of low DHEAS levels can be considered a marker of the adrenocortical origin of an adrenal Incidentaloma, provided adrenal failure has been excluded.Keywords
This publication has 18 references indexed in Scilit:
- Plasma 3 beta-hydroxy-delta 5-steroids in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiencyThe Journal of Clinical Endocrinology & Metabolism, 1994
- Clinical review 50: Clinically silent adrenal massesThe Journal of Clinical Endocrinology & Metabolism, 1993
- Preclinical Cushing's syndrome in adrenal "incidentalomas": comparison with adrenal Cushing's syndromeThe Journal of Clinical Endocrinology & Metabolism, 1992
- Subtle glucocorticoid excess in patients with adrenal incidentalomaThe American Journal of Medicine, 1992
- Hormonal Evaluation of the Patient with an Incidentally Discovered Adrenal MassNew England Journal of Medicine, 1990
- Adrenal insufficiency after operative removal of apparently nonfunctioning adrenal adenomasJAMA, 1989
- Cortisol Secretion by an Incidentally Discovered Nonfunctional Adrenal Adenoma*The Journal of Clinical Endocrinology & Metabolism, 1986
- Evidence for Adrenocortical Adaptation to Severe Illness*The Journal of Clinical Endocrinology & Metabolism, 1985
- Clinical and laboratory findings and results of therapy in 58 patients with adrenocortical tumors admitted to a single medical center (1951 to 1978)The American Journal of Medicine, 1981
- REVIEW ARTICLE: ACTH AND RELATED PEPTIDESClinical Endocrinology, 1980